MATI 03/2563 February 28, 2020 Subject Report on Year End Period Consolidated Financial Statement which ended on December 31, 2019 To Director and Manager The Stock Exchange of Thailand Matichon

20240205-ADVANC-MDA-4Q23-EN 4Q23 & FY23 MD&A Advanced Info Service Plc. 1 Executive Summary Achieved solid revenue growth from core business focus and TTTBB acquisitions. FY23, the Thai economy

growth in export sales while domestics market we sustain the leadership position in the RTD Tea market. Moreover, the Company started to earn services revenue from OEM business in this quarter. Food

were back on track with 44.5% growth YoY and 3.4% growth QoQ. - In Q1’19, the Company maintained its leadership position with total market share of 31.1% in Brain and Body Boost (“BBB”) products which

ADVANC-MDA-1Q24-EN 1Q24 MD&A Advanced Info Service Plc. 1 Executive Summary Revenue base expansion from core business growth and acquisition of TTTBB 1Q24, Thai consumer confidence slightly improved

with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000

beverages continued its growth momentum at 7.3% YoY, and domestic personal care showed 23.7% growth. Overall international business grew 8.7% at constant FX rate. YTD 1H’19, net sales grew 5.0%, contributed

( “ 3Q19” ) was THB 460. 51 million, increased 8% yoy. The non-social security (“non-SW”) revenue and social security (“SW”) revenue grew by 6% and 11% respectively. The growth of non-SW revenue was driven

; Beverages business The beverage sales and services revenue was Baht 6,501 million, increased by Baht 515 million or 8.6% from last year which was Baht 5,986 million, driven by strong growth in export sales

incurred from deferred tax. This extra transaction was included in year ended 2017 financial statement for the net amount of THB 24 million. Revenue from Hospital Operations Revenue from hospital operations